PFE / Allergan inversion deal got its last nail in the coffin and is past history now. From technical point of view, the price broke out from an ascending channel, we take the first oscillation height (in pink) as a rough guideline for defining the next target. This target area is matching SSB and Kijun levels seen in the past as well, especially the flat cloud level at Fall 2015 around 32.5.
Komentarz:
www.telegraph.co.uk/...erger-with-allergan/
Transakcja zamknięta: osiągnięto wyznaczony cel